Featured Research

from universities, journals, and other organizations

New Mechanism Of Resistance To Dengue Virus

Date:
November 4, 2008
Source:
CNRS
Summary:
It is becoming increasingly common to see individuals infected by the dengue virus who develop an ultimately fatal hemorrhagic syndrome, particularly in children during epidemics. However, in most cases, dengue remains a generally benign or even asymptomatic viral infection. One explanation for this phenomenon is a new mechanism of resistance to dengue virus could form the basis for new strategies to prevent this disease.

Internalization of a dengue virus protein (green fluorescence differing as a function of cell type: macrophage vs. dendritic cells) Macrophages: The protein is restricted to the cell periphery (thus protecting it from infection)
Credit: Copyright Laboratoire Immunologie et chimie thérapeutiques (CNRS/Université Louis Pasteur)

It is becoming increasingly common to see individuals infected by the dengue virus who develop an ultimately fatal hemorrhagic syndrome, particularly in children during epidemics. However, in most cases, dengue remains a generally benign or even asymptomatic viral infection.

One explanation for this phenomenon has just been put forward by researchers from CNRS, Institut Pasteur, Inserm and the University of Berkeley (in a recent publication in the journal PloS NTD. The demonstration of a new mechanism of resistance to dengue virus could form the basis for new strategies to prevent this disease.

Among the cells in the immune system, dermal dendritic cells are described as the initial cell targets of dengue virus at the site of inoculation by its vector, the mosquito. An interaction between the viral glycoprotein envelope and the CD209/DC-SIGN surface molecule of dermal dendritic cells may be the principal event that triggers infection of these cells and then disseminates the dengue virus throughout the infected individual.

The scientists observed that human dermal macrophages(4) expressing CD209/DC-SIGN were able to capture the dengue virus inoculated by the mosquito without the virus being able to multiply. This unexpected inhibition of viral replication, despite the virus being present in the macrophage, has recently been demonstrated by a group of researchers from CNRS, Institut Pasteur, Inserm and the University of Berkeley who were collaborating on this project on dengue. Their report constitutes the first description of a new resistance mechanism that represents an important innate defence system against dengue virus infection in humans.

Each year, dengue affects more than 100 million people out of the two billion who live in regions infested by the vector mosquito Aedes aegypti. This disease constitutes a growing public health problem linked to the extension of infested zones and the increase in the number of severe cases in regions with high endemicity. It has become the principal emerging vector-borne viral disease in tropical and subtropical regions of South-East Asia and Latin America, including French overseas departments and territories such as the French West Indies and Guiana, and French Polynesia. In mainland France, dengue has been a notifiable disease since 2006.


Story Source:

The above story is based on materials provided by CNRS. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kwan et al. Dermal-Type Macrophages Expressing CD209/DC-SIGN Show Inherent Resistance to Dengue Virus Growth. PLoS Neglected Tropical Diseases, 2008; 2 (10): e311 DOI: 10.1371/journal.pntd.0000311

Cite This Page:

CNRS. "New Mechanism Of Resistance To Dengue Virus." ScienceDaily. ScienceDaily, 4 November 2008. <www.sciencedaily.com/releases/2008/10/081016085029.htm>.
CNRS. (2008, November 4). New Mechanism Of Resistance To Dengue Virus. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2008/10/081016085029.htm
CNRS. "New Mechanism Of Resistance To Dengue Virus." ScienceDaily. www.sciencedaily.com/releases/2008/10/081016085029.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins